These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14998577)

  • 1. In vitro permeation of several drugs through the human nail plate: relationship between physicochemical properties and nail permeability of drugs.
    Kobayashi Y; Komatsu T; Sumi M; Numajiri S; Miyamoto M; Kobayashi D; Sugibayashi K; Morimoto Y
    Eur J Pharm Sci; 2004 Mar; 21(4):471-7. PubMed ID: 14998577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro.
    Vejnovic I; Huonder C; Betz G
    Int J Pharm; 2010 Sep; 397(1-2):67-76. PubMed ID: 20620203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing effect of N-acetyl-l-cysteine or 2-mercaptoethanol on the in vitro permeation of 5-fluorouracil or tolnaftate through the human nail plate.
    Kobayashi Y; Miyamoto M; Sugibayashi K; Morimoto Y
    Chem Pharm Bull (Tokyo); 1998 Nov; 46(11):1797-802. PubMed ID: 9845958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydration of nail plate: a novel screening model for transungual drug permeation enhancers.
    Chouhan P; Saini TR
    Int J Pharm; 2012 Oct; 436(1-2):179-82. PubMed ID: 22705091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers.
    Murthy SN; Vaka SR; Sammeta SM; Nair AB
    J Pharm Sci; 2009 Nov; 98(11):4264-71. PubMed ID: 19363796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.
    McAuley WJ; Jones SA; Traynor MJ; Guesné S; Murdan S; Brown MB
    Eur J Pharm Biopharm; 2016 May; 102():178-84. PubMed ID: 26969264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug permeation through the three layers of the human nail plate.
    Kobayashi Y; Miyamoto M; Sugibayashi K; Morimoto Y
    J Pharm Pharmacol; 1999 Mar; 51(3):271-8. PubMed ID: 10344627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A drug-in-adhesive anti-onychomycotic nail patch: Influence of drug and adhesive nature on drug release, ungual permeation, in vivo residence in human and anti-fungal efficacy.
    Rizi K; Xu K; Begum T; Faull J; Bhakta S; Murdan S
    Int J Pharm; 2022 Feb; 614():121437. PubMed ID: 34973408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Size and Charge Dependence of Ion Transport in Human Nail Plate.
    Baswan SM; Li SK; LaCount TD; Kasting GB
    J Pharm Sci; 2016 Mar; 105(3):1201-8. PubMed ID: 26886342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of different formulations for drug delivery through the nail plate.
    Vejnovic I; Simmler L; Betz G
    Int J Pharm; 2010 Feb; 386(1-2):185-94. PubMed ID: 19941943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Hansen Solubility Parameters to predict drug-nail interactions, which can assist the design of nail medicines.
    Hossin B; Rizi K; Murdan S
    Eur J Pharm Biopharm; 2016 May; 102():32-40. PubMed ID: 26924329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical characterization of the human nail: permeation pattern for water and the homologous alcohols and differences with respect to the stratum corneum.
    Walters KA; Flynn GL; Marvel JR
    J Pharm Pharmacol; 1983 Jan; 35(1):28-33. PubMed ID: 6131961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
    Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H
    Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ungual and transungual drug delivery.
    Shivakumar HN; Juluri A; Desai BG; Murthy SN
    Drug Dev Ind Pharm; 2012 Aug; 38(8):901-11. PubMed ID: 22149347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microstructural alterations in the onychomycotic and psoriatic nail: Relevance in drug delivery.
    Cutrín Gómez E; Anguiano Igea S; Delgado-Charro MB; Gómez Amoza JL; Otero Espinar FJ
    Eur J Pharm Biopharm; 2018 Jul; 128():48-56. PubMed ID: 29673870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug delivery to the nail following topical application.
    Murdan S
    Int J Pharm; 2002 Apr; 236(1-2):1-26. PubMed ID: 11891066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro permeability of the human nail and of a keratin membrane from bovine hooves: influence of the partition coefficient octanol/water and the water solubility of drugs on their permeability and maximum flux.
    Mertin D; Lippold BC
    J Pharm Pharmacol; 1997 Jan; 49(1):30-4. PubMed ID: 9120766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nail swelling as a pre-formulation screen for the selection and optimisation of ungual penetration enhancers.
    Khengar RH; Jones SA; Turner RB; Forbes B; Brown MB
    Pharm Res; 2007 Dec; 24(12):2207-12. PubMed ID: 17665289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1st meeting on topical drug delivery to the nail.
    Murdan S
    Expert Opin Drug Deliv; 2007 Jul; 4(4):453-5. PubMed ID: 17683257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.